AVR
HEALTHCAREAnteris Technologies Global Corp
$6.39+0.20 (+3.23%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving AVR Today?
No stock-specific AI insight has been generated for AVR yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$2.85$6.95
$6.39
Fundamentals
Market Cap$621M
P/E Ratio—
EPS$-2.55
Dividend Yield—
Dividend / Share—
ROE-3.0%
Profit Margin—
Debt / Equity—
Trading
Volume637K
Avg Volume (10D)—
Shares Outstanding97.2M
AVR News
20 articles- Anteris secures US Medicare coverage for PARADIGM Trial as DurAVR study advancesProactive Investors·May 7, 2026
- Anteris treats first US patients in DurAVR pivotal trialProactive Investors·May 7, 2026
- Anteris Technologies enrolls First US patients in global PARADIGM trial for DurAVR heart valveYahoo Finance·May 6, 2026
- Small Cap Watch: Small Ordinaries edges higher as company news flow continuesProactive Investors·May 6, 2026
- Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM TrialYahoo Finance·May 5, 2026
- Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM TrialGlobeNewswire Inc.·Apr 28, 2026
- A new valve, a new playbook: How Anteris is trying to reshape a $10B heart marketProactive Investors·Apr 2, 2026
- Truffle Capital Unveils the First Edition of the Truffle MedTech 10Yahoo Finance·Mar 18, 2026
- Anteris Technologies Global CEO Touts DurAVR Redesign, Durability Claims and TAVR Market StrategyMarketbeat·Mar 12, 2026
- Anteris Technologies Global Highlights DurAVR TAVR Data, PARADIGM Pivotal Trial Plans at TD Cowen ConferenceMarketbeat·Mar 5, 2026
- Anteris reports US$77.8m 2025 net operating cash outflow as PARADIGM trial gets underwayProactive Investors·Feb 26, 2026
- Anteris Reports 2025 Financial Results and Provides Corporate UpdateYahoo Finance·Feb 26, 2026
- Anteris to Present at Healthcare Investor Conferences TD Cowen and BarclaysYahoo Finance·Feb 23, 2026
- Anteris Technologies price target lowered to $15 from $20 at Lake StreetYahoo Finance·Jan 24, 2026
- Retail investors who hold 25% of Anteris Technologies Global Corp. (ASX:AVR) gained 41%, institutions profited as wellYahoo Finance·Jan 23, 2026
- Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital RaisesYahoo Finance·Jan 22, 2026
- Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common StockYahoo Finance·Jan 22, 2026
- Anteris Technologies announces $200M public offering to fund clinical growthYahoo Finance·Jan 22, 2026
- Medtronic to buy up to $90M stake in heart valve developer AnterisMedtechdive·Jan 21, 2026
- Anteris Technologies Global Corp. Announces Pricing of $200 Million Public OfferingYahoo Finance·Jan 21, 2026
All 20 articles loaded
Price Data
Open$6.23
Previous Close$6.19
Day High$6.58
Day Low$6.20
52 Week High$6.95
52 Week Low$2.85
52-Week Range
$2.85$6.95
$6.39
Fundamentals
Market Cap$621M
P/E Ratio—
EPS$-2.55
Dividend Yield—
Dividend / Share—
ROE-3.0%
Profit Margin—
Debt / Equity—
Trading
Volume637K
Avg Volume (10D)—
Shares Outstanding97.2M
About Anteris Technologies Global Corp
Anteris Technologies Global Corp. The company is headquartered in Toowong, Australia.
HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL INSTRUMENTS & SUPPLIES
CIK—
Composite FIGI—
Share Class FIGI—